Her2 promotes early dissemination of breast cancer by inhibiting the p38 pathway through the downregulation of MAP3K4
Abstract Early dissemination refers to the process by which cancer cells spread to distant organs at an early stage of the disease, often before the primary tumor is clinically detectable. Experimental studies have demonstrated that Her2 promotes early dissemination of breast cancer by inhibiting th...
Saved in:
| Main Authors: | Guanwen Wang, Ping Wen, Ting Xue, Yuxin Huang, Qing Shao, Ningning Zhang, Fanli Qu, Jing Wang, Nan Wang, Xiaohua Zeng |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-12-01
|
| Series: | Cell Communication and Signaling |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12964-024-02000-2 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
ERBB2/HOXB13 co-amplification with interstitial loss of BRCA1 defines a unique subset of breast cancers
by: Irene Rin Mitsiades, et al.
Published: (2024-12-01) -
METTL14-mediated m6A modification upregulates HOXB13 expression to activate NF-κB and exacerbate cervical cancer progression
by: Qian Li, et al.
Published: (2024-12-01) -
Efficacy of Next-Generation Sequencing in Identifying Genetic Markers for Prostate Cancer Risk
by: Fahad H. Alaithan, et al.
Published: (2024-12-01) -
Analysis of factors influencing the efficacy of NAC and prognosis between HER2-zero and HER2-low HR negative breast cancer
by: Jing-Jing Liu, et al.
Published: (2024-11-01) -
Study on the matching scheme between early warning information dissemination demands and communication network dissemination channels
by: Jingli WANG, et al.
Published: (2022-05-01)